Elsevier

Vaccine

Volume 9, Issue 2, February 1991, Pages 111-116
Vaccine

Paper
Antibody assays suitable for assessing immune responses to live varicella vaccine

https://doi.org/10.1016/0264-410X(91)90266-9Get rights and content

Abstract

An enzyme-linked immunosorbent assay for antibodies to varicella-zoster virus (VZV), using purified viral glycoproteins as antigen (gpELISA), was compared with other assays for measuring vaccine-induced antibody responses. The gpELISA was more sensitive than conventional assays, proved highly specific for VZV and agreed well with an assay for neutralizing antibody activity. It was successfully applied to large-scale testing of live varicella vaccine in humans.

References (30)

  • Watson, B., Keller, P.M., Ellis, R.W. and Starr, S.E. Cell-mediated immune responses after immunization of healthy...
  • Bergen, R.E., Diaz, P.S. and Arvin, A.M. The immunogenicity of the Oka-Merck varicella vaccine in relation to...
  • V. Williams et al.

    Serologic responses to varicella zoster membrane antigens measured by indirect immunofluorescence

    J. Infect. Dis.

    (1974)
  • Z. Shehab et al.

    Enzyme-linked immunosorbent assay for susceptibility to varicella

    J. Infect. Dis.

    (1983)
  • Wasmuth, E.H. and Miller, W.J. A sensitive enzyme-linked immunosorbent assay (ELISA) for antibody to varicella zoster...
  • Cited by (0)

    View full text